Readers are directed to the PDF version of this article.
Publisher’s note: This guidance has been reviewed in 2020 and is considered to be out of date. Up-to-date guidance, including an algorithm for testing, can be found in this consensus statement.
Combination of GLP-1 and amylin agonist results in significant weight loss and HbA1c reduction.
14 Aug 2026